Gujchem Distilleries , operating as ZR2 Bioenergy Limited, has announced a crucial board meeting scheduled for September 3, 2025. The meeting agenda includes the consideration of a final dividend on equity shares for the Financial Year 2024-25, subject to shareholder approval at the upcoming Annual General Meeting.

Key Points

• Board Meeting Date: September 3, 2025
• Primary Agenda: Recommendation of final dividend for FY 2024-25
• Additional Consideration: Determination of record date for dividend eligibility

Dividend Deliberation

The board of directors will convene to deliberate on the recommendation of a final dividend for the equity shareholders. This decision, if approved by the board, will be subject to further approval by the shareholders at the ensuing Annual General Meeting.

Record Date Determination

An important aspect of the meeting will be the fixation of the record date. This date will be crucial for determining the eligibility of shareholders to receive the final dividend, should it be recommended and subsequently approved.

Corporate Communication

The announcement was made through an official intimation to the BSE Limited, where ZR2 Bioenergy is listed. Shital Gurav, the Company Secretary and Compliance Officer, communicated this information in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Company Background

ZR2 Bioenergy Limited, formerly known as Gujchem Distillers India Limited, maintains its registered office in Ahmedabad and a corporate office in Mumbai. The company's CIN is L32909GJ1939PLC002480, indicating its long-standing presence in the Indian corporate landscape.

Investors and stakeholders are advised to keep an eye on the outcomes of this board meeting, as it may have implications for their shareholdings in ZR2 Bioenergy Limited. The company has stated that this information will also be available on its official website at https://gujchemdistillers.in for public access.

Gujchem Distilleries (formerly known as Gujchem Distillers India Limited) has announced its financial results for the first quarter, reporting a net profit of ₹30.85 crore. This marks a significant turnaround from the loss of ₹79.05 crore reported in the same quarter of the previous year.

Financial Highlights

The company's performance for Q1 is summarized in the following table:

Key Observations

1. Other Income Boost: Despite no revenue from operations, ZR2 Bioenergy saw a substantial increase in other income, rising from ₹4.42 lakh to ₹46.43 lakh, a remarkable growth of 950.45%.

2. Expense Management: The company significantly reduced its total expenses from ₹83.47 lakh to ₹15.67 lakh, a reduction of 81.23%. This played a crucial role in turning the company's performance from loss to profit.

3. Profitability: ZR2 Bioenergy reported a net profit of ₹30.85 crore, compared to a net loss of ₹79.05 crore in the same quarter last year.

4. Earnings Per Share: The Basic Earnings Per Share (EPS) improved from -₹2.21 to ₹0.86.

Corporate Developments

The company has undergone significant changes:

1. Change in Control: ZR2 Group Holdings Limited acquired a 61% stake (21,77,110 equity shares) from the previous management, becoming the new promoter of the company.

2. Subsidiary Incorporation: ZR2 Solar Private Limited, a wholly-owned subsidiary of ZR2 Bioenergy, was incorporated. This subsidiary is set to operate in the renewable energy sector, focusing on generating, distributing, and supplying various forms of renewable energy.

3. Capital Raising: The company issued and allotted 2,59,22,000 convertible warrants at ₹65 per warrant and 1,23,50,000 compulsory convertible debentures at ₹65 each to promoter groups and strategic investors.

Jimmy Olsson, Managing Director of ZR2 Bioenergy Limited, signed off on the financial results, which were approved by the Board of Directors. The results have been subjected to a limited review by the statutory auditors, who expressed an unqualified opinion.

The company's transition into the renewable energy sector, coupled with its improved financial performance, signals a new direction for ZR2 Bioenergy Limited. Investors and stakeholders will be watching closely to see how the company leverages its new subsidiary and capital infusion to generate operational revenue in the coming quarters.